Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

NCT03602638 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1

Interventions

DRUG: Sitagliptin
DRUG: Acarbose

Sponsor

Chinese PLA General Hospital